亚太诊断成像设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按产品(MRI、计算机断层扫描、超声、X 射线、核成像、荧光透视和乳房 X 光检查)、应用、最终用户和地理细分

市场快照

asia pacific diagnostic imaging equipment market share
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 7.5 %
asia pacific diagnostic imaging equipment market key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

市场受到越来越重视早期诊断的高度影响。早期发现慢性疾病,如癌症,大大增加了成功治疗的机会。因此,发展中国家的医疗保健部门正在强调这些疾病的早期发现,而不是花费在昂贵的治疗上。政府组织正在开展计划,以提高对早期诊断的认识。随着亚太地区慢性病病例数量的增加,对疾病早期诊断以进行有效治疗的需求可能会推动该地区的诊断成像市场。

报告范围

诊断成像用于使用电磁辐射拍摄人体内部结构的图像,以准确诊断患者。诊断成像使用辐射来诊断和治疗疾病。所研究的市场受到多种因素的推动,例如不断发展的技术进步,包括手持式 X 射线和直立式 MRI,以及研究人员对医学成像设备的兴趣日益浓厚。

By Modality
MRI
Low and mid field MRI systems (<1.5 T)
High field MRI systems (1.5-3 T)
Very High, and Ultra High Field MRI Systems (3T and more)
Computed Tomography
Low End Scanners (~16-Slice)
Mid Range Scanners (~64-Slice)
High End Scanners (128-Slice and More)
Ultrasound
2D Ultrasound
3D Ultrasound
Others
X-Ray
Analog Systems
Digital Systems
Nuclear Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Fluoroscopy
Mammography
By Application
Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Other Applications
By End-User
Hospital
Diagnostic Centers
Others
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

X 射线占据市场的主要部分

X 射线是一种非侵入性医学测试,可帮助医生诊断和治疗疾病。X 射线成像涉及将身体的一部分暴露在小剂量的电离辐射下,以产生身体内部的图像。

由于对移动 X 射线系统、改造升级套件、医院和诊断中心数量的增长、数字技术的进步、无痛和非侵入性的需求不断增长,预计 X 射线成像系统将在预测年份增长程序,与其他方式相比价格低廉,人口老龄化的增加以及伤害和疾病的发病率上升。

asia pacific diagnostic imaging equipment market trends

竞争格局

亚太地区诊断成像设备市场的主要参与者包括 Carestream Health、Fujifilm Holdings Corporation、GE Healthcare、Hitachi Medical Corporation、Hologic, Inc.、Koninklijke Philips NV、Shimadzu Corporation、Siemens AG、佳能医疗系统公司和上海联合影像医疗有限公司等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Technological Advancement in Imaging Modalities

      3. 4.2.3 Growing Emphasis on Early Diagnosis

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Radiologist

      2. 4.3.2 High Cost of Advanced Diagnostic Imaging Devices

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Modality

      1. 5.1.1 MRI

        1. 5.1.1.1 Low and mid field MRI systems (<1.5 T)

        2. 5.1.1.2 High field MRI systems (1.5-3 T)

        3. 5.1.1.3 Very High, and Ultra High Field MRI Systems (3T and more)

      2. 5.1.2 Computed Tomography

        1. 5.1.2.1 Low End Scanners (~16-Slice)

        2. 5.1.2.2 Mid Range Scanners (~64-Slice)

        3. 5.1.2.3 High End Scanners (128-Slice and More)

      3. 5.1.3 Ultrasound

        1. 5.1.3.1 2D Ultrasound

        2. 5.1.3.2 3D Ultrasound

        3. 5.1.3.3 Others

      4. 5.1.4 X-Ray

        1. 5.1.4.1 Analog Systems

        2. 5.1.4.2 Digital Systems

      5. 5.1.5 Nuclear Imaging

        1. 5.1.5.1 Positron Emission Tomography (PET)

        2. 5.1.5.2 Single Photon Emission Computed Tomography (SPECT)

      6. 5.1.6 Fluoroscopy

      7. 5.1.7 Mammography

    2. 5.2 By Application

      1. 5.2.1 Cardiology

      2. 5.2.2 Oncology

      3. 5.2.3 Neurology

      4. 5.2.4 Orthopedics

      5. 5.2.5 Gastroenterology

      6. 5.2.6 Gynecology

      7. 5.2.7 Other Applications

    3. 5.3 By End-User

      1. 5.3.1 Hospital

      2. 5.3.2 Diagnostic Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 Asia-Pacific

        1. 5.4.1.1 China

        2. 5.4.1.2 Japan

        3. 5.4.1.3 India

        4. 5.4.1.4 Australia

        5. 5.4.1.5 South Korea

        6. 5.4.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Carestream Health

      2. 6.1.2 FUJIFILM Holdings Corporation

      3. 6.1.3 GE Healthcare

      4. 6.1.4 Hitachi Medical Corporation

      5. 6.1.5 Hologic, Inc.

      6. 6.1.6 Koninklijke Philips N.V.

      7. 6.1.7 Shanghai United Imaging Healthcare Co., Ltd

      8. 6.1.8 Shimadzu Corporation

      9. 6.1.9 Siemens AG

      10. 6.1.10 Canon Medical Systems Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Diagnostic Imaging Equipment Market market is studied from 2018 - 2026.

The Asia-Pacific Diagnostic Imaging Equipment Market is growing at a CAGR of 7.5% over the next 5 years.

Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic, Inc are the major companies operating in Asia-Pacific Diagnostic Imaging Equipment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!